15. Korea Disease Control and Prevention Agency. COVID-19 vaccination in Korea [Internet]. KDCA; 2023 [cited 2023 Dec 6]. Available from:
https://ncv.kdca.go.kr
19. Hallberg E, Sundstrom A, Larsson M, Arthurson V, Ljung R. Association between menstrual cycle length and coronavirus disease 2019 (COVID-19) vaccination: a U.S. cohort. Obstet Gynecol 2022;139:940-1.
22. Mohr-Sasson A, Haas J, Abuhasira S, Sivan M, Doitch Amdurski H, Dadon T, et al. The effect of Covid-19 mRNA vaccine on serum anti-Mullerian hormone levels. Hum Reprod 2022;37:534-41.
24. Male V. Menstrual changes after COVID-19 vaccination. BMJ 2021;374:n2211.
25. Messinis IE. Ovarian feedback, mechanism of action and possible clinical implications. Hum Reprod Update 2006;12:557-71.
26. Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL, Stillman RJ. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 1995;64:1136-40.
27. Abdalla H, Thum MY. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 2004;19:893-8.
28. Jenkins JM, Anthony FW, Lee A, Masson GM, Thomas E. Persistent elevation of serum oestradiol levels by functional ovarian cysts despite effective pituitary desensitization with GnRH agonists. Clin Endocrinol (Oxf) 1994;40:357-9.
29. Casablanca Y. Management of dysfunctional uterine bleeding. Obstet Gynecol Clin North Am 2008;35:219-34.
30. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction. Obstet Gynecol 2013;122:176-85.
32. Reed BG, Carr BR. The normal menstrual cycle and the control of ovulation. In: Feingold KR, Anawalt B, Blackman MR, editors. Endotext. MDText.com Inc.; 2000 [cited 2023 Dec 6]. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK279054
35. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril 2020;114:1151-7.